Resultados de la búsqueda 191-200 of 9801 for akathisia

1. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to document the primary investigator's clinical experience performing Ultrasound Guided Carpal Tunnel Release (USCTR) in the ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   By evaluating 30 patients undergoing robotic mitral annuloplasty, this study aims to establish the feasibility of further prospective evaluation of CT and MRI ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

4. Hematología - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

7. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to delineate the neural mechanisms of VNS-REHAB (Vagus Nerve Stimulation paired with task-specific upper limb rehabilitation). A ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    Linvoseltamab has previously been studied as a single agent (without other cancer treatments) in participants with multiple myeloma that returned after prior ...